N-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide

C61H70FN9O6 — CID 176552436

IUPACN-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide
SMILESCC(C)c1cc(C(=O)N2Cc3ccc(CN4CCC(C(=O)N(C)[C@H]5CN6CCC[C@@]6(COc6nc(N7CC8CC9CCC9CC(C7)N8)c7cnc(-c8cc(O)cc9ccccc89)c(F)c7n6)C5)CC4)cc3C2)c(O)cc1O
InChIInChI=1S/C61H70FN9O6/c1-35(2)48-24-50(53(74)25-52(48)73)59(76)70-29-41-10-9-36(19-42(41)30-70)28-68-17-13-37(14-18-68)58(75)67(3)45-26-61(15-6-16-71(61)33-45)34-77-60-65-56-51(57(66-60)69-31-43-20-38-11-12-39(38)21-44(32-69)64-43)27-63-55(54(56)62)49-23-46(72)22-40-7-4-5-8-47(40)49/h4-5,7-10,19,22-25,27,35,37-39,43-45,64,72-74H,6,11-18,20-21,26,28-34H2,1-3H3/t38?,39?,43?,44?,45-,61+/m1/s1
InChIKeyLRTZPJSKBLPDLP-VCNUTKHPSA-N
MW1044.29 g/mol
LogP8.70
Rot. Bonds11

About N-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide

N-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide (PubChem CID 176552436) has the molecular formula C61H70FN9O6 and a molecular weight of 1044.29 g/mol. Its IUPAC name is N-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide.

Molecular Properties

Compound NameN-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide
PubChem CID176552436
Molecular FormulaC61H70FN9O6
Molecular Weight1044.29 g/mol
Exact Mass1043.54
IUPAC NameN-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide
SMILESCC(C)c1cc(C(=O)N2Cc3ccc(CN4CCC(C(=O)N(C)[C@H]5CN6CCC[C@@]6(COc6nc(N7CC8CC9CCC9CC(C7)N8)c7cnc(-c8cc(O)cc9ccccc89)c(F)c7n6)C5)CC4)cc3C2)c(O)cc1O
InChIInChI=1S/C61H70FN9O6/c1-35(2)48-24-50(53(74)25-52(48)73)59(76)70-29-41-10-9-36(19-42(41)30-70)28-68-17-13-37(14-18-68)58(75)67(3)45-26-61(15-6-16-71(61)33-45)34-77-60-65-56-51(57(66-60)69-31-43-20-38-11-12-39(38)21-44(32-69)64-43)27-63-55(54(56)62)49-23-46(72)22-40-7-4-5-8-47(40)49/h4-5,7-10,19,22-25,27,35,37-39,43-45,64,72-74H,6,11-18,20-21,26,28-34H2,1-3H3/t38?,39?,43?,44?,45-,61+/m1/s1
InChIKeyLRTZPJSKBLPDLP-VCNUTKHPSA-N
XLogP8.70
TPSA170.96 Ų
H-Bond Donors4
H-Bond Acceptors13
Rotatable Bonds11
Heavy Atoms77
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001044.29
LogP ≤ 58.70
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1013

Analyze N-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide?
The IUPAC name of N-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide (CID 176552436) is N-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide.
What is the SMILES notation for N-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide?
The canonical SMILES for N-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide is CC(C)c1cc(C(=O)N2Cc3ccc(CN4CCC(C(=O)N(C)[C@H]5CN6CCC[C@@]6(COc6nc(N7CC8CC9CCC9CC(C7)N8)c7cnc(-c8cc(O)cc9ccccc89)c(F)c7n6)C5)CC4)cc3C2)c(O)cc1O.
What is the InChIKey of N-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide?
The InChIKey is LRTZPJSKBLPDLP-VCNUTKHPSA-N. The full InChI is InChI=1S/C61H70FN9O6/c1-35(2)48-24-50(53(74)25-52(48)73)59(76)70-29-41-10-9-36(19-42(41)30-70)28-68-17-13-37(14-18-68)58(75)67(3)45-26-61(15-6-16-71(61)33-45)34-77-60-65-56-51(57(66-60)69-31-43-20-38-11-12-39(38)21-44(32-69)64-43)27-63-55(54(56)62)49-23-46(72)22-40-7-4-5-8-47(40)49/h4-5,7-10,19,22-25,27,35,37-39,43-45,64,72-74H,6,11-18,20-21,26,28-34H2,1-3H3/t38?,39?,43?,44?,45-,61+/m1/s1.
What are the key properties of N-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide?
N-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide has a molecular weight of 1044.29 g/mol, XLogP of 8.70, 11 rotatable bonds, 4 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2R,8S)-8-[[4-(10,12-diazatricyclo[6.3.1.03,6]dodecan-10-yl)-8-fluoro-7-(3-hydroxynaphthalen-1-yl)pyrido[4,3-d]pyrimidin-2-yl]oxymethyl]-1,2,3,5,6,7-hexahydropyrrolizin-2-yl]-1-[[2-(2,4-dihydroxy-5-propan-2-ylbenzoyl)-1,3-dihydroisoindol-5-yl]methyl]-N-methylpiperidine-4-carboxamide is sourced from PubChem (CID 176552436), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).